期刊文献+

8-异前列腺素F2α与高血压及阻塞性睡眠呼吸暂停低通气综合征

Relationship between 8-iso-prostaglandin F2α, hypertension and obstructive sleep apnea-hypopea syndrome
原文传递
导出
摘要 8-异前列腺素F2α(8-iso—prostaglandin F2α,8-iso—PGF2α)是机体内脂质过氧化反应的特异性产物,是评价氧化应激和脂质过氧化反应理想的生物学指标。阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea—hypopnea syndrome,OSAHS)是一种常见的睡眠呼吸紊乱疾病,常并发高血压病。8iso—PGF2α不仅能敏感反映OSAHS的氧化应激状态,并可能为OSAHS并发高血压的预测因子,现就8-iso—PGF2α与高血压及OSAHS的相关性作一综述。 8-iso-prostaglandin F2α (8-iso-PGF2α ) which is a specific product of the lipid peroxidation,is an index to appraise the oxidative stress and lipid peroxidization ideal biology target. Obstructive sleep apneahypopnea syndrome(OSAHS) is a common disease of disordered breathing, with higher risk of developing hypertention. Studies show that 8-iso-PGF2α can be not only as an evaluation of OSAHS patients with oxidative stress in a sensitive indicator, also may be a predictor of hypertension in OSAHS patients. The review is about the relationship between 8-iso-PGF2α ,hypertension and OSAHS.
出处 《国际呼吸杂志》 2009年第5期283-286,共4页 International Journal of Respiration
关键词 阻塞性睡眠呼吸暂停低通气综合征 高血压 8-异前列腺素F2Α 氧化应激 Obstructive sleep apnea-hypopnea syndrome Hypertension 8-iso-prostaglandinF2α Oxidative stress
  • 相关文献

参考文献26

  • 1Patrignani P,Tacconelli S. Isoprostanes and other markers of peroxidation in atherosclerosis. Biomarkers 2005, 10 ( Suppl 1 ) : S24-S29.
  • 2Carpagnano GE, Kharitonov SA, Resta O, et al. 8- isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest, 2003,124 : 1386-1392.
  • 3Morrow JD, Harris TM, Roberts LJ 2nd. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem,1990,184: 1-10.
  • 4Sametz W,Grobuschek T, Hammer Kogler S.et al. Influence of isoprostanes on vasoconstrictor effects of noradrenaline and angiotensin II. Eur J Pharmacol, 1999,378 : 47-55.
  • 5Basu S. Isoprostanes: novel bioactive products of lipid peroxida tion. Free Radic Res, 2004,38 :105-122.
  • 6Comporti M, Signorini C, Arezzini B, et al. F2-isoprostanes are not just markers of oxidative stress. Free Radic Biol Med, 2008,44:247-256.
  • 7Morrow JD. The isoprostanes unique products of arachidonate peroxidation:their role as mediators of oxidant stress. Curr Pharm Des, 2006,12 : 895-902.
  • 8Montuschi P, Barnes PJ, Roberts LJ 2nd. lsoprostanes: markers and mediators of oxidative stress. FASEB J. 2004, 18:1791-1800.
  • 9Gopaul NK, Zacharowski K. Halliwell B, et al. Evaluation of the postprandial effects of a fast-food meal on human plasma F(2)-isoprostane levels. Free Radic Biol Med. 2000,28: 806- 814.
  • 10Helmersson J, Basu S. F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot Essent Fatty Acids, 1999,61:203-205.

二级参考文献4

  • 1Murdeach Reilly,et al.Modulation of oxidant sturess in vivo in chronic cigarette smokers[].Circulation.1996
  • 2Zhaoyue Wang,et al.Immunological characterization of urinary 8EPI -prostaglandinF2 excretion in man[].J of Pharmacology and Experimental Therapeutics.1997
  • 3GiovanniDavi,etal.In vivo formation of8-ISO-ProstaglandinF.andplatelet activation in diabetes mellitus[].Circulation.1999
  • 4John F,et al.Diabetees, oxidative stress, and platetet activation[].Circulation.1999

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部